Mediterranean Diet, Circuit Resistance Training, Empagliflozin in Elderly With Type 2 Diabetes: a Study Protocol
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT03560375
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT03560375
-
- Other papers using this trial's data
- Clinical similarity, economic divergence: cost-effectiveness and population health implications of dietary, pharmacological, and exercise interventions in older adults with type 2 diabetes: a secondary analysis of a randomized controlled trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Israel
- Registry status
- Completed
Technical summary
Registry record NCT03560375. Randomized; single masking; primary purpose treatment. Start 2018-05-09 (actual); primary completion 2021-02-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Mediterranean Diet, Circuit Resistance Training, Empagliflozin in Elderly With Type 2 Diabetes: a Study Protocol
- Condition
- Diabetes Mellitus, Type 2
- Condition
- Sarcopenia
- Condition
- Weight Loss
- Intervention (Behavioral)
- Circuit resistance training (CRT)
- Intervention (Behavioral)
- Vegeterranean diet (V-Med diet)
- Intervention (Drug)
- Empagliflozin 10 MG
- Lead sponsor
- Tel-Aviv Sourasky Medical Center
Record details
- Record id
cardio:ct-nct03560375- Content hash
d9fc0f30ecc251db23e5c6c671274b66aa501f7ea4c5c59398c0f34e631890ac